Literature DB >> 10361914

Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins.

A Kusuda1, K Migita, M Tsuboi, M Degawa, N Matsuoka, M Tominaga, A Kawakami, Y Kawabe, T Taguchi, K Eguchi.   

Abstract

A 26-year-old woman was admitted for the evaluation of edema and massive proteinuria. She had a history of purpura of the lower extremities, abdominal pain and melena. Laboratory investigations showed hypoalbuminemia, hypercholesterolemia and proteinuria of over 10 g/day. Renal biopsy showed moderate proliferative glomerulonephritis with mesangial immunoglobulin A (IgA) deposition. She was diagnosed as having Henoch-Schonlein purpura nephritis. Oral prednisolone, dipyridamole and intravenous heparin treatment were not effective. Steroid pulse therapy induced a partial improvement of proteinuria to 2-3 g/day. High-dose intravenous immunoglobulin (i.v.-IG) treatment was introduced and a dramatic improvement of proteinuria was noted. I.v.-IG should be fully considered in patients with steroid-resistant Henoch-Schonlein purpura nephritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361914     DOI: 10.2169/internalmedicine.38.376

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Henoch-Schönlein purpura: a clinical case with dramatic presentation.

Authors:  João Bento; Adriana Magalhães; Conceição Souto Moura; Venceslau Hespanhol
Journal:  BMJ Case Rep       Date:  2010-09-09

Review 2.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

3.  An adult case of severe steroid-resistant Henoch-Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomy.

Authors:  Emi Sasaki; Maki Shibata; Asami Kato; Naoto Hamano; Takashi Katsuki; Manami Tada; Fumihiko Hinoshita
Journal:  CEN Case Rep       Date:  2016-07-13

4.  The clinical implications of adult-onset henoch-schonelin purpura.

Authors:  Warit Jithpratuck; Yasmin Elshenawy; Hana Saleh; George Youngberg; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-27

5.  The efficiency of intraperitoneal high-dose immunoglobulin in experimental nephrotic syndrome.

Authors:  Seyhan Erisir; Halide Akbas; Mustafa Koyun; Sema Akman
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

Review 6.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

7.  [Analysis of clinical characteristics of Henoch-Schonlein purpura patients from different altitudes in plateau areas].

Authors:  H Wei; Z Luo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

8.  Henoch-Schönlein purpura (HSP) and high-dose immunoglobulin treatment in patient with familiar prostatic adenocarcinoma.

Authors:  Małgorzata Sobieszczańska; Sławomir Tubek; Dagmara Poplicha; Anna Grabelus; Jacek Pawełczak
Journal:  Hum Vaccin Immunother       Date:  2014-04-14       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.